Quick Answer
NovaBridge Biosciences reported Revenue (ASC 606) of $13.81 million for fiscal year 2021.
NovaBridge Biosciences Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2021 | $13.81M | -99.1% |
| 2020 | $1.54B | +5042.2% |
| 2019 | $30.00M | -44.2% |
| 2018 | $53.78M | +365.4% |
| 2017 | $11.56M | — |
- NovaBridge Biosciences showed a decrease of -99.1% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2017–2021 period, NovaBridge Biosciences’s revenue (asc 606) has grown by 19.5% (from $11.56 million to $13.81 million).
- The most recent figure is from NovaBridge Biosciences’s fiscal year 2021 report (Form 20-F), filed with the SEC on April 29, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: